Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 05 - 04    tags : Collaboration    save search

908 Devices and Bio-Techne Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.55 -0.72% -0.72% 270K twitter stocktwits trandingview |
| | O: -0.25% H: 0.19% C: -0.57%
TECH | $63.675 1.39% 1.37% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.67% C: -0.74%

collaboration device
Bio-Techne and 908 Devices Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.55 -0.72% -0.72% 270K twitter stocktwits trandingview |
| | O: -0.25% H: 0.19% C: -0.57%
TECH | $63.675 1.39% 1.37% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.67% C: -0.74%

collaboration device
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements– Agreements are a major step for ongoing clinical trials and future commercial drug supply
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
PSTV | News | $1.65 -0.6% -0.61% 17K twitter stocktwits trandingview |
Health Technology
| | O: 15.77% H: 17.61% C: -20.27%

ongoing clinical trials collaboration drug trial chmp
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements
Published: 2021-05-04 (Crawled : 12:00) - globenewswire.com
PSTV | News | $1.65 -0.6% -0.61% 17K twitter stocktwits trandingview |
Health Technology
| | O: 15.77% H: 17.61% C: -20.27%

collaboration drug chmp
Evotec and the GCKD Study Enter into Strategic Collaboration to Build A Unique Molecular Patient Database
Published: 2021-05-04 (Crawled : 08:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.32% C: -0.59%

unique collaboration molecular
Press news Biocartis Group NV: Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer
Published: 2021-05-04 (Crawled : 06:00) - globenewswire.com
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 0.21% C: -0.64%

lung cancer test collaboration cancer biomarkers
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.